DAIC

APRIL 16, 2024

While PCI, which includes both angioplasty and stenting, is one of the most common operations in the world, it does carry a small (about 1-2%) but significant risk of death. in total, angioplasty and stenting was deemed to be of low value and potentially avoidable nearly one third of the time.

Angioplasty 111

Angioplasty Stents Stent Heart Attack 111

Medical Xpress - Cardiology

JANUARY 17, 2024

By inflating a balloon and potentially placing a stent, they can help blood flow more freely from the heart. When a person has one or more blocked arteries, providers may choose to conduct a minimally invasive procedure known as percutaneous coronary intervention, or PCI.

Stents 89

Stents Stent Angioplasty 89

Open Heart

JANUARY 19, 2024

Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Aims To estimate the 1-year cost-effectiveness of stepwise provisional versus systematic dual stenting strategies. Uncertainty was explored by probabilistic bootstrapping.

Stents 98

Stents Stent Myocardial Infarction Outcomes 98

JAMA Cardiology

MARCH 12, 2024

This randomized clinical trial compares 12-month event rates using quantitative coronary angiography guidance during percutaneous coronary intervention with those after intravascular ultrasonography–guided stent implantation.

Stents 82

Stents Stent 82

Frontiers in Cardiovascular Medicine

DECEMBER 18, 2023

Objectives There is no consensus regarding the optimal choice between single long stent (SLS) and overlapped double short stents (DSS) in patients with acute myocardial infarction (AMI). Therefore, we aimed to compare treatment outcomes among patients with AMI treated with these two different stenting methods. years, and 75.0%

Stents 64

Stents Stent Myocardial Infarction Outcomes 64

Becker's Hospital Review - Cardiology

JUNE 3, 2024

based HonorHealth Research and Innovation Institute is among the first facilities in the nation — and one of 30 worldwide — to use new stroke prevention stents, according to a May 29 news release. Scottsdale, Ariz.-based

Stents 69

Stents Stent Stroke Strokes 69

American College of Cardiology

JUNE 3, 2024

What are the outcomes of transcatheter occlusion of sinus venosus defects (SVD) with covered stent?

Stents 61

Stents Stent Outcomes Article 61

Science Daily - Heart Disease

APRIL 8, 2024

New research could change standard-of-care guidelines to improve outcomes for heart attack patients after coronary stenting procedures.

Heart Attack 73

Heart Attack Heart attacks Stents Stent 73

Med Page Today

APRIL 29, 2024

(MedPage Today) -- The FDA approved the Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the knee, Abbott announced on Monday. This system represents the first drug-eluting resorbable scaffold with.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Stents Stent Ischemia 111

Frontiers in Cardiovascular Medicine

JANUARY 31, 2024

Objectives The purpose of this study was to assess the clinical outcome after right ventricular outflow tract (RVOT) stenting in late presenter patient with unrepaired Fallot physiology. Results During the procedure, the average stent diameter and length were 8.84 ± 1.64 mm The Statistical Package for Social Science (SPSS) 26.0

Stents 64

Stents Stent Physiology ICU 64

JAMA Cardiology

NOVEMBER 26, 2024

This study compares clopidogrel vs aspirin monotherapy in patients with high bleeding risk and/or percutaneous coronary intervention complexity.

Stents 110

Stents Stent 110

Becker's Hospital Review - Cardiology

JUNE 20, 2024

based Atrium Health Sanger Heart & Vascular Institute has become the first in the world to implant a new Duo venous stent system. Charlotte, N.C.-based

Stents 64

Stents Stent 64

Dr. Paddy Barrett

DECEMBER 5, 2023

The logic of stenting obstructed coronary arteries is simple. A stent unblocks the artery. Subscribe now Stenting stable coronary artery disease has not been convincingly proven to reduce the risk of future heart attacks or death 1. But coronary stenting is not the only way to reduce symptoms of angina. All is fixed.

Stents 59

Stents Stent Angina Heart Attack 59

HCPLive

APRIL 29, 2024

Abbott's Esprit BTK System was shown to significantly reduce risk of ischemic events in patients with PAD versus angioplasty over 1 year.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Angioplasty Stents Stent 111

DAIC

MARCH 8, 2024

a company focused on reducing the risk of stroke and its devastating impact, today announced that it has launched its Tapered ENROUTE Transcarotid Stent System to hospitals in the United States. New tapered configurations for our ENROUTE Transcarotid Stent System build upon the robust portfolio of Silk Road’s carotid solutions.

Stents 59

Stents Stent Anatomy Plaque 59

Med Page Today

SEPTEMBER 1, 2024

(MedPage Today) -- LONDON -- Some individuals already undergoing transcatheter aortic valve replacement (TAVR, also TAVI) might as well get coronary lesions revascularized around the same time, according to the NOTION-3 randomized trial. Clinical.

TAVR 98

TAVR Aortic valve Stents Stent 98

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI). cases, the target lesion was in-stent restenosis (ISR). Results A total of 425 patients were enrolled at 13 centers (mean age 66.9 ± 11.6

Stents 64

Stents Stent Cardiogenic Shock Coronary Artery Disease 64

Coronary Artery Disease Journal

JULY 30, 2024

No abstract available

Stents 74

Stents Stent 74

DAIC

OCTOBER 16, 2024

Smits and a distinguished team of international researchers, the trial compares the performance of SMT's biodegradable-polymer sirolimus-eluting Supraflex Cruz stent with the biodegradable-polymer Ultimaster Tansei * stent in patients with high bleeding risk (HBR) undergoing abbreviated dual antiplatelet therapy (DAPT).

Stents 52

Stents Stent Thrombosis Coronary Artery Disease 52

DAIC

MAY 30, 2024

The prospective, international, multicenter single-arm observational study evaluated the treatment of de novo, restenotic or occluded iliac lesions in 160 patients with Rutherford Class 2-6 peripheral artery disease using the Dynetic-35 cobalt chromium balloon-expandable stent system. At baseline, 12.5% stenosis in the target lesion. “The

Stents 69

Stents Stent Peripheral Arterial Disease Innovation 69

DAIC

JANUARY 31, 2024

(Gore) announced recent FDA approval of a lower profile GORE VIABAHN VBX Balloon Expandable Endoprosthesis ( VBX Stent Graft ). 1-3 "Our team is pleased to be the first commercial implanter of the new lower profile VBX Stent Graft," said Darren Schneider , M.D., No changes to the stent design were made to achieve the lower profile.

Stents 111

Stents Stent Innovation Aortic 111

American College of Cardiology

SEPTEMBER 2, 2024

The goal of the REC-CAGEFREE I trial was to assess the safety and efficacy of a paclitaxel-coated balloon (DCB) compared to drug-eluting stent (DES) implantation among patients with coronary in-stent restenosis.

Stents 49

Stents Stent Angioplasty Article 49

Frontiers in Cardiovascular Medicine

JULY 25, 2024

The past five years have yielded impressive advancements in fully absorbable metal stent technology. Nowhere is the need for fully absorbable metal stents greater than in patients experiencing vascular anomalies associated with congenital heart disease (CHD).

Stents 52

Stents Stent Pediatrics Congenital Heart Disease 52

Med Page Today

MARCH 16, 2024

(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center.

Stents 105

Stents Stent 105

Med Page Today

OCTOBER 28, 2024

(MedPage Today) -- For percutaneous coronary intervention (PCI) on de novo lesions, the DynamX bioadaptor not only matched drug-eluting stents (DES) in early performance but seemed to keep stent-related events from accruing after 6 months, according.

Stents 52

Stents Stent 52

Frontiers in Cardiovascular Medicine

FEBRUARY 18, 2024

Drug-eluting stents (DES) play a crucial role in treating coronary artery disease (CAD) by preventing restenosis. These stents are coated with drug carriers that release antiproliferative drugs within the vessel. The most cited document pertained to standardized definitions for clinical endpoints in coronary stent trials.

Coronary Artery Disease 59

Coronary Artery Disease Stents Stent Research 59

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

A hybrid technique using a single-branched thoracic stent-graft (Castor, MicroPort Medical, Shanghai, China) in combination with a surgical left subclavian-carotid bypass and endovascular occlusion of the poststenotic aneurysm using a vascular plug device (Amplatzer Vascular Plug, Abbott, Chicago, United States) was performed.

Stents 75

Stents Stent Stenosis Aneurysm 75

DAIC

JANUARY 19, 2024

announced that the first patients have been enrolled in the Gore VBX FORWARD Clinical Study ( NCT05811364 ), a global prospective, multicenter, randomized controlled trial to compare the GORE VIABAHN VBX Balloon Expandable Endoprosthesis (VBX Stent Graft) to bare metal stenting for patients with complex iliac occlusive disease. "Our

Stents 107

Stents Stent Anatomy Outcomes 107

Cardiology Update

JULY 28, 2024

A recent study published in JACC: Cardiovascular Interventions has provided new insights into the long-term management of patients suffering from recurrent in-stent restenosis (ISR), a condition presenting notable challenges in cardiovascular treatment. The median follow-up period was 10.3 Original article: Koch T et al.

Stents 52

Stents Stent Cardiovascular Interventions Research 52

Becker's Hospital Review - Cardiology

NOVEMBER 7, 2024

A drug-eluting resorbable stent was found to be just as effective in treating infrapopliteal artery disease in patients at risk of limb amputation, according to a study published Oct. 25 in the New England Journal of Medicine.

Stents 52

Stents Stent Angioplasty Outcomes 52

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

In the present case, a 76-year-old hypertensive woman was admitted with dizziness and diagnosed with an unruptured bronchial artery aneurysm, which was treated by transcatheter arterial embolization and aortic stent-graft. The patient's clinical status was stable during the 4-year follow-up.

Embolism 59

Embolism Aneurysm Stents Stent 59

American College of Cardiology

NOVEMBER 26, 2024

Use of intravascular lithotripsy (IVL) for the treatment of in-stent restenosis (ISR), although off-label, may be safe and feasible, according to a study reviewing data from the ACC's CathPCI Registry published in JACC: Cardiovascular Interventions.

Stents 49

Stents Stent Cardiovascular Interventions Article 49

Journal of Cardiovascular Electrophysiology

NOVEMBER 20, 2024

The stenosis was treated with a stent. years later he presented with an in-stent restenosis that was successfully treated with a stent-in-stent strategy. Conclusion Our case demonstrates stenting as a viable alternative strategy with potentiallyfavorable long-term outcome.

Stents 40

Stents Stent Pulmonary Angioplasty 40

Med Page Today

JULY 25, 2024

(MedPage Today) -- For interventionalists hoping that a new generation of coronary balloons might improve treatment of in-stent restenosis (ISR), contemporary registry data were encouraging. In a propensity score-matched analysis of 335 pairs.

Stents 52

Stents Stent 52

Medical Xpress - Cardiology

APRIL 4, 2024

Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally invasive procedure to unclog the arteries that feed the heart.

Angioplasty 97

Angioplasty Stents Stent Research 97

Frontiers in Cardiovascular Medicine

NOVEMBER 6, 2024

Inner or outer short bridging stents were applied to fabricate PMSG with the help of 3D-printing models intraoperatively. DiscussionThe application of short bridging stents has shown promising results in reducing endoleak rates after F/B EVAR. In aortic arch group, the average operative time was 289.2 ± 88.8 min.

Stents 59

Stents Stent Aortic 59

Frontiers in Cardiovascular Medicine

MARCH 12, 2024

In this phenomenon, a thrombus forms within the lumen of the stent graft component of the frozen elephant trunk prosthesis and puts the patient at risk for downstream embolization with visceral or lower limb ischemia. The long-term efficiency of these prophylactic and therapeutic measures has yet to be proven.

Stents 59

Stents Stent Risk Factors Thrombosis 59